Sudeep Pharma Ltd EPS

Sudeep Pharma Ltd EPS

Image

Sudeep Pharma Ltd

NSE: SUDEEPPHRM

EPS

₹ 14.89

Last updated on: Mar 20, 2026

Key Highlights

  • The Earning per Share of Sudeep Pharma Ltd is ₹ 14.89 as of 20 Mar 26 The earning per share of Sudeep Pharma Ltd changed from ₹ 4.49 to ₹ 4.29 over 7 quarters. This represents a CAGR of -2.57% .

Historical Earning per Share of Sudeep Pharma Ltd

No data available

* All values are in

Company Fundamentals for Sudeep Pharma Ltd

Market Cap

6,929 Cr

EPS

14.9

P/E Ratio (TTM)

41.2

P/B Ratio (TTM)

8.4

Day’s High

621.0

Day’s Low

604.15

DTE

0.2

ROE

20.6

52 Week High

795.8

52 Week Low

524.95

ROCE

23.8

Market Price of Sudeep Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Sudeep Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Mar 2026613.55
19 Mar 2026598.35
18 Mar 2026620.1
17 Mar 2026602
16 Mar 2026596.35
13 Mar 2026594
12 Mar 2026608.4
11 Mar 2026618.15
10 Mar 2026593.85
09 Mar 2026557.6

SWOT Analysis Of Sudeep Pharma Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Sudeep Pharma Ltd

Asset Value vs Market Value of Sudeep Pharma Ltd

Market Value

6,930

Asset Value

Value addition

15.3 X

426

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Sudeep Pharma Ltd6929
Sun Pharmaceutical Industries Ltd426470
Divis Laboratories Ltd161996
Torrent Pharmaceuticals Ltd144440
Dr Reddys Laboratories Ltd108417
Lupin Ltd106146

Historical Market Cap of Sudeep Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Sudeep Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Sudeep Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Sudeep Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Sudeep Pharma Ltd News Hub

Sudeep Pharma to declare Quarterly Results

Sudeep Pharma will hold a meeting of the Board of Directors of the Company on 19 December 2025. Powe

Read more

16 Dec 25

Sudeep Pharma IPO subscribed 1.42 times

Sudeep Pharma received bids for 1,50,09,425 shares as against 1,05,64,926 shares on offer, according

Read more

21 Nov 25

Sudeep Pharma IPO subscribed 5.09 times

Sudeep Pharma received bids for 5,37,83,650 shares as against 1,05,64,926 shares on offer, according

Read more

24 Nov 25

Sudeep Pharma IPO subscribed 93.71 times

Sudeep Pharma received bids for 99,00,86,575 shares as against 1,05,64,926 shares on offer, accordin

Read more

25 Nov 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Sudeep Pharma Ltd

What is the EPS of Sudeep Pharma Ltd stock?

The Earnings Per Share (EPS) of Sudeep Pharma Ltd is 14.89. An EPS is the amount of net income attributed to each share of a common stock.

How is Sudeep Pharma Ltd EPS calculated?

The EPS of Sudeep Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Sudeep Pharma Ltd report its EPS?

Sudeep Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Sudeep Pharma Ltd EPS?

Factors that influence the EPS of Sudeep Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Sudeep Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Sudeep Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions